Newsroom

Default Image

AIR Communities Recognized as Real Estate Top Workplace by Energage

AIR Communities, a leading real estate investment trust, has been distinguished as a Real Estate Top Workplace by Energage, a...

Jul 24, 2025 Press Release
Default Image

Texas Mineral Resources Corp. Announces Promising Drilling Results in New...

Texas Mineral Resources Corp. (TMRC) has released preliminary exploratory drilling results from the Black Hawk Mining District in Grant County,...

Jul 24, 2025 Press Release
Default Image

AstraZeneca’s $50 Billion Investment in Virginia Highlights Maryland’s Missed Opportunities

AstraZeneca’s announcement of a $50 billion investment in U.S. operations by 2030, with a significant portion dedicated to a new...

Jul 24, 2025 Press Release
Default Image

New Research Highlights Strategies for Scaling Hiring Without Losing Quality

The latest findings from the HR Research Institute’s study, ‘HR.com’s State of Seasonal, Hourly and Volume Hiring 2025’, underscore the...

Jul 24, 2025 Press Release
Default Image

Green Monke’s Hemp-Infused Happy Sodas Lead Non-Alcoholic Beverage Sales at...

Green Monke, an award-winning hemp-D9 beverage brand, has reported significant success with its Happy Sodas at the Pabst Theatre Group...

Jul 24, 2025 Press Release
Default Image

BitFrontier Capital Holdings, Inc. Announces Strategic Turnaround Under New CEO...

BitFrontier Capital Holdings, Inc. (OTC: BFCH), a company previously focused on cryptocurrency mining and hosting services, has announced a significant...

Jul 24, 2025 Press Release
Default Image

Hero Response Expands Its Restoration Services to Ontario with Two...

Hero Response, a nationally recognized full-service restoration leader, has announced the expansion of its operations to include two new locations...

Jul 24, 2025 Press Release
Default Image

ABVC BioPharma and OncoX BioPharma Strengthen Oncology Collaboration with $100,000...

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, has announced the receipt of a $100,000 milestone payment from OncoX BioPharma, Inc.,...

Jul 24, 2025 Press Release
Default Image

GeoVax Revises Gedeptin® Clinical Strategy Following KEYNOTE-689 Trial Results

GeoVax Labs, Inc. has announced a significant update to its Gedeptin® clinical development program, shifting focus towards evaluating Gedeptin as...

Jul 24, 2025 Press Release